Zobrazeno 1 - 10
of 10
pro vyhledávání: '"O'BRIEN FL"'
Autor:
Mantegazza, R, Wolfe, GI, Muppidi, S, Wiendl, H, Fujita, KP, O'Brien, FL, Booth, HDE, Howard, JF, Illa I., Cortés-Vicente E., Díaz-Manera J., Querol L.A., Rojas-García R., Vidal-Fernandez N., REGAIN Study Group
Publikováno v:
NEUROLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Objective To evaluate whether eculizumab helps patients with anti-acetylcholine receptor-positive (AChR+) refractory generalized myasthenia gravis (gMG) achieve the Myasthenia Gravis Foundation of America (MGFA) post-intervention status of minimal ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::93c76f5ed578cc0c5f93c483f596575f
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7922
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7922
Autor:
Muppidi, S, Utsugisawa, K, Benatar, M, Murai, H, Barohn, RJ, Illa, I, Jacob, S, Vissing, J, Burns, TM, Kissel, JT, Nowak, RJ, Andersen, H, Casasnovas, C, de Bleecker, JL, Vu, TH, Mantegazza, R, O'Brien, FL, Wang, JJ, Fujita, KP, Howard, JF, Kaya, A, Khursigara, G, Armstrong, R, Diab, D, Capocelli, K, Lane, C, Sanders, V, Gandolfo, R, REGAIN Study Grp
Publikováno v:
MUSCLE & NERVE
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Introduction: Eculizumab is effective and well tolerated in patients with antiacetylcholine receptor antibody-positive refractory generalized myasthenia gravis (gMG; REGAIN; NCT01997229). We report an interim analysis of an open-label extension of RE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::5c85c74958e047c20f2e7ab4bd48c959
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2597
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2597
Autor:
Howard JF Jr; Department of Neurology, The University of North Carolina, Chapel Hill, North Carolina, USA., Karam C; Department of Neurology, Oregon Health & Science University, Portland, Oregon, USA., Yountz M; Alexion Pharmaceuticals, Inc., Boston, Massachusetts, USA., O'Brien FL; Alexion Pharmaceuticals, Inc., Boston, Massachusetts, USA., Mozaffar T; Department of Neurology, University of California, Irvine, California, USA.
Publikováno v:
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2021 Jul; Vol. 8 (7), pp. 1398-1407. Date of Electronic Publication: 2021 May 27.
Autor:
Mantegazza R; From the Fondazione IRCCS Istituto Neurologico Carlo Besta (R.M.), Milan, Italy; Department of Neurology (G.I.W.), Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York; Department of Neurology and Neurological Sciences (S.M.), Stanford University School of Medicine, Palo Alto, CA; Department of Neurology (H.W.), University of Münster, Germany; Alnylam Pharmaceuticals (K.P.F.), Cambridge, MA; Alexion Pharmaceuticals (F.L.O.), Boston, MA; Oxford PharmaGenesis (H.D.E.B.), UK; and Department of Neurology (J.F.H.), University of North Carolina, Chapel Hill. K.P.F. was formerly affiliated with Alexion Pharmaceuticals, Boston, MA., Wolfe GI; From the Fondazione IRCCS Istituto Neurologico Carlo Besta (R.M.), Milan, Italy; Department of Neurology (G.I.W.), Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York; Department of Neurology and Neurological Sciences (S.M.), Stanford University School of Medicine, Palo Alto, CA; Department of Neurology (H.W.), University of Münster, Germany; Alnylam Pharmaceuticals (K.P.F.), Cambridge, MA; Alexion Pharmaceuticals (F.L.O.), Boston, MA; Oxford PharmaGenesis (H.D.E.B.), UK; and Department of Neurology (J.F.H.), University of North Carolina, Chapel Hill. K.P.F. was formerly affiliated with Alexion Pharmaceuticals, Boston, MA., Muppidi S; From the Fondazione IRCCS Istituto Neurologico Carlo Besta (R.M.), Milan, Italy; Department of Neurology (G.I.W.), Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York; Department of Neurology and Neurological Sciences (S.M.), Stanford University School of Medicine, Palo Alto, CA; Department of Neurology (H.W.), University of Münster, Germany; Alnylam Pharmaceuticals (K.P.F.), Cambridge, MA; Alexion Pharmaceuticals (F.L.O.), Boston, MA; Oxford PharmaGenesis (H.D.E.B.), UK; and Department of Neurology (J.F.H.), University of North Carolina, Chapel Hill. K.P.F. was formerly affiliated with Alexion Pharmaceuticals, Boston, MA., Wiendl H; From the Fondazione IRCCS Istituto Neurologico Carlo Besta (R.M.), Milan, Italy; Department of Neurology (G.I.W.), Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York; Department of Neurology and Neurological Sciences (S.M.), Stanford University School of Medicine, Palo Alto, CA; Department of Neurology (H.W.), University of Münster, Germany; Alnylam Pharmaceuticals (K.P.F.), Cambridge, MA; Alexion Pharmaceuticals (F.L.O.), Boston, MA; Oxford PharmaGenesis (H.D.E.B.), UK; and Department of Neurology (J.F.H.), University of North Carolina, Chapel Hill. K.P.F. was formerly affiliated with Alexion Pharmaceuticals, Boston, MA., Fujita KP; From the Fondazione IRCCS Istituto Neurologico Carlo Besta (R.M.), Milan, Italy; Department of Neurology (G.I.W.), Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York; Department of Neurology and Neurological Sciences (S.M.), Stanford University School of Medicine, Palo Alto, CA; Department of Neurology (H.W.), University of Münster, Germany; Alnylam Pharmaceuticals (K.P.F.), Cambridge, MA; Alexion Pharmaceuticals (F.L.O.), Boston, MA; Oxford PharmaGenesis (H.D.E.B.), UK; and Department of Neurology (J.F.H.), University of North Carolina, Chapel Hill. K.P.F. was formerly affiliated with Alexion Pharmaceuticals, Boston, MA., O'Brien FL; From the Fondazione IRCCS Istituto Neurologico Carlo Besta (R.M.), Milan, Italy; Department of Neurology (G.I.W.), Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York; Department of Neurology and Neurological Sciences (S.M.), Stanford University School of Medicine, Palo Alto, CA; Department of Neurology (H.W.), University of Münster, Germany; Alnylam Pharmaceuticals (K.P.F.), Cambridge, MA; Alexion Pharmaceuticals (F.L.O.), Boston, MA; Oxford PharmaGenesis (H.D.E.B.), UK; and Department of Neurology (J.F.H.), University of North Carolina, Chapel Hill. K.P.F. was formerly affiliated with Alexion Pharmaceuticals, Boston, MA., Booth HDE; From the Fondazione IRCCS Istituto Neurologico Carlo Besta (R.M.), Milan, Italy; Department of Neurology (G.I.W.), Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York; Department of Neurology and Neurological Sciences (S.M.), Stanford University School of Medicine, Palo Alto, CA; Department of Neurology (H.W.), University of Münster, Germany; Alnylam Pharmaceuticals (K.P.F.), Cambridge, MA; Alexion Pharmaceuticals (F.L.O.), Boston, MA; Oxford PharmaGenesis (H.D.E.B.), UK; and Department of Neurology (J.F.H.), University of North Carolina, Chapel Hill. K.P.F. was formerly affiliated with Alexion Pharmaceuticals, Boston, MA., Howard JF Jr; From the Fondazione IRCCS Istituto Neurologico Carlo Besta (R.M.), Milan, Italy; Department of Neurology (G.I.W.), Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York; Department of Neurology and Neurological Sciences (S.M.), Stanford University School of Medicine, Palo Alto, CA; Department of Neurology (H.W.), University of Münster, Germany; Alnylam Pharmaceuticals (K.P.F.), Cambridge, MA; Alexion Pharmaceuticals (F.L.O.), Boston, MA; Oxford PharmaGenesis (H.D.E.B.), UK; and Department of Neurology (J.F.H.), University of North Carolina, Chapel Hill. K.P.F. was formerly affiliated with Alexion Pharmaceuticals, Boston, MA. howardj@neurology.unc.edu.
Publikováno v:
Neurology [Neurology] 2021 Jan 26; Vol. 96 (4), pp. e610-e618. Date of Electronic Publication: 2020 Nov 23.
Autor:
Nowak RJ; Department of Neurology, Yale University School of Medicine, New Haven, CT, United States., Muppidi S; Department of Neurology and Neurosciences, Stanford University School of Medicine, Stanford, CA, United States., Beydoun SR; Department of Neurology, University of Southern California, Los Angeles, CA, United States., O'Brien FL; Alexion Pharmaceuticals, Boston, MA, United States., Yountz M; Alexion Pharmaceuticals, Boston, MA, United States., Howard JF Jr; Department of Neurology, University of North Carolina, Chapel Hill, NC, United States.
Publikováno v:
Frontiers in neurology [Front Neurol] 2020 Nov 24; Vol. 11, pp. 556104. Date of Electronic Publication: 2020 Nov 24 (Print Publication: 2020).
Autor:
Mantegazza R; Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy., O'Brien FL; Alexion Pharmaceuticals, Boston, MA., Yountz M; Alexion Pharmaceuticals, Boston, MA., Howard JF Jr; Department of Neurology, University of North Carolina, Chapel Hill, NC.
Publikováno v:
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2020 Aug; Vol. 7 (8), pp. 1327-1339. Date of Electronic Publication: 2020 Jul 22.
Autor:
Muppidi S; Department of Neurology and Neurosciences, Stanford University School of Medicine, Stanford, California, USA., Utsugisawa K; Department of Neurology, Hanamaki General Hospital, Hanamaki, Japan., Benatar M; Department of Neurology, University of Miami Miller School of Medicine, Miami, Florida, USA., Murai H; Department of Neurology, International University of Health and Welfare, Narita, Japan., Barohn RJ; Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, USA., Illa I; Neurology Department, Hospital Sant Pau, Autonomous University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Spain., Jacob S; Queen Elizabeth Neuroscience Centre and Wellcome Trust Clinical Research Facility, University Hospital Birmingham, Birmingham, United Kingdom., Vissing J; Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Burns TM; Department of Neurology, University of Virginia Health System, Charlottesville, Virginia, USA., Kissel JT; Department of Neurology, The Ohio State University, Columbus, Ohio, USA., Nowak RJ; Department of Neurology, Yale School of Medicine, Yale University, New Haven, Connecticut, USA., Andersen H; Department of Neurology, Aarhus University Hospital, Aarhus, Denmark., Casasnovas C; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Spain.; Department of Neurology, Bellvitge University Hospital, Barcelona, Spain., de Bleecker JL; Neuromuscular Reference Centre, Ghent University Hospital, Ghent, Belgium., Vu TH; Department of Neurology, University of South Florida, Tampa, Florida, USA., Mantegazza R; Foundation of the Carlo Besta Neurological Institute, IRCSS, Milan, Italy., O'Brien FL; Alexion Pharmaceuticals, Boston, Massachusetts, USA., Wang JJ; Alexion Pharmaceuticals, Boston, Massachusetts, USA., Fujita KP; Alexion Pharmaceuticals, Boston, Massachusetts, USA., Howard JF Jr; Department of Neurology, University of North Carolina, Chapel Hill, North Carolina, USA.
Publikováno v:
Muscle & nerve [Muscle Nerve] 2019 Jul; Vol. 60 (1), pp. 14-24. Date of Electronic Publication: 2019 Mar 08.
Publikováno v:
Journal of the National Association of Chiropodists [J Natl Assoc Chirop] 1956 Jun; Vol. 46 (6), pp. 376-82.
Autor:
O'Brien FL, Olver JW
Publikováno v:
Analytical chemistry [Anal Chem] 1969 Nov; Vol. 41 (13), pp. 1810-3.
Publikováno v:
Journal of the National Association of Chiropodists [J Natl Assoc Chirop] 1957 Dec; Vol. 47 (12), pp. 601-8.